BCL6 and colorectal cancer: Moreover, the expression level of Bcl6 in Treg cells negatively correlates with the pathological grading of colorectal cancer, indicated by progressively increased proportion of Bcl6hi Treg cells from pathological stage I to stage IV (TNM stage) colorectal cancer patients (Figure 5B).